HIV Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: H2064DEDBBE2EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of HIV Diagnosis and Treatment in Global, including the following market information:

Global HIV Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HIV Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibody Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HIV Diagnosis and Treatment include Siemens Healthcare, Abbott, Roche, Bio-Rad, QIAGEN, Danaher, BD, Merck and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HIV Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HIV Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibody Tests
• Viral Identification Assays
• Cd4 Testing
• Viral Load Testing
• Early Infant Diagnostics

Global HIV Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HIV Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)

• Diagnostic Laboratories
• Hospitals
• Blood Banks
• Home Care Settings

Global HIV Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HIV Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HIV Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HIV Diagnosis and Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Siemens Healthcare
• Abbott
• Roche
• Bio-Rad
• QIAGEN
• Danaher
• BD
• Merck
• BioMerieux
• MedMira
• Hologic

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HIV Diagnosis and Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HIV Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HIV DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE

2.1 Global HIV Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global HIV Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HIV Diagnosis and Treatment Players in Global Market
3.2 Top Global HIV Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global HIV Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 HIV Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Diagnosis and Treatment Players in Global Market
  3.6.1 List of Global Tier 1 HIV Diagnosis and Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 HIV Diagnosis and Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HIV Diagnosis and Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibody Tests
  4.1.3 Viral Identification Assays
  4.1.4 Cd4 Testing
  4.1.5 Viral Load Testing
  4.1.6 Early Infant Diagnostics
4.2 By Type - Global HIV Diagnosis and Treatment Revenue & Forecasts
  4.2.1 By Type - Global HIV Diagnosis and Treatment Revenue, 2017-2022
  4.2.2 By Type - Global HIV Diagnosis and Treatment Revenue, 2023-2028
  4.2.3 By Type - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HIV Diagnosis and Treatment Market Size, 2021 & 2028
  5.1.2 Diagnostic Laboratories
  5.1.3 Hospitals
  5.1.4 Blood Banks
  5.1.5 Home Care Settings
5.2 By Application - Global HIV Diagnosis and Treatment Revenue & Forecasts
  5.2.1 By Application - Global HIV Diagnosis and Treatment Revenue, 2017-2022
  5.2.2 By Application - Global HIV Diagnosis and Treatment Revenue, 2023-2028
  5.2.3 By Application - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HIV Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global HIV Diagnosis and Treatment Revenue & Forecasts
  6.2.1 By Region - Global HIV Diagnosis and Treatment Revenue, 2017-2022
  6.2.2 By Region - Global HIV Diagnosis and Treatment Revenue, 2023-2028
  6.2.3 By Region - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HIV Diagnosis and Treatment Revenue, 2017-2028
  6.3.2 US HIV Diagnosis and Treatment Market Size, 2017-2028
  6.3.3 Canada HIV Diagnosis and Treatment Market Size, 2017-2028
  6.3.4 Mexico HIV Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HIV Diagnosis and Treatment Revenue, 2017-2028
  6.4.2 Germany HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.3 France HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.4 U.K. HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.5 Italy HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.6 Russia HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries HIV Diagnosis and Treatment Market Size, 2017-2028
  6.4.8 Benelux HIV Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HIV Diagnosis and Treatment Revenue, 2017-2028
  6.5.2 China HIV Diagnosis and Treatment Market Size, 2017-2028
  6.5.3 Japan HIV Diagnosis and Treatment Market Size, 2017-2028
  6.5.4 South Korea HIV Diagnosis and Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia HIV Diagnosis and Treatment Market Size, 2017-2028
  6.5.6 India HIV Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HIV Diagnosis and Treatment Revenue, 2017-2028
  6.6.2 Brazil HIV Diagnosis and Treatment Market Size, 2017-2028
  6.6.3 Argentina HIV Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HIV Diagnosis and Treatment Revenue, 2017-2028
  6.7.2 Turkey HIV Diagnosis and Treatment Market Size, 2017-2028
  6.7.3 Israel HIV Diagnosis and Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia HIV Diagnosis and Treatment Market Size, 2017-2028
  6.7.5 UAE HIV Diagnosis and Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Siemens Healthcare
  7.1.1 Siemens Healthcare Corporate Summary
  7.1.2 Siemens Healthcare Business Overview
  7.1.3 Siemens Healthcare HIV Diagnosis and Treatment Major Product Offerings
  7.1.4 Siemens Healthcare HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.1.5 Siemens Healthcare Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott HIV Diagnosis and Treatment Major Product Offerings
  7.2.4 Abbott HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche HIV Diagnosis and Treatment Major Product Offerings
  7.3.4 Roche HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Bio-Rad
  7.4.1 Bio-Rad Corporate Summary
  7.4.2 Bio-Rad Business Overview
  7.4.3 Bio-Rad HIV Diagnosis and Treatment Major Product Offerings
  7.4.4 Bio-Rad HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Key News
7.5 QIAGEN
  7.5.1 QIAGEN Corporate Summary
  7.5.2 QIAGEN Business Overview
  7.5.3 QIAGEN HIV Diagnosis and Treatment Major Product Offerings
  7.5.4 QIAGEN HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.5.5 QIAGEN Key News
7.6 Danaher
  7.6.1 Danaher Corporate Summary
  7.6.2 Danaher Business Overview
  7.6.3 Danaher HIV Diagnosis and Treatment Major Product Offerings
  7.6.4 Danaher HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.6.5 Danaher Key News
7.7 BD
  7.7.1 BD Corporate Summary
  7.7.2 BD Business Overview
  7.7.3 BD HIV Diagnosis and Treatment Major Product Offerings
  7.7.4 BD HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.7.5 BD Key News
7.8 Merck
  7.8.1 Merck Corporate Summary
  7.8.2 Merck Business Overview
  7.8.3 Merck HIV Diagnosis and Treatment Major Product Offerings
  7.8.4 Merck HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.8.5 Merck Key News
7.9 BioMerieux
  7.9.1 BioMerieux Corporate Summary
  7.9.2 BioMerieux Business Overview
  7.9.3 BioMerieux HIV Diagnosis and Treatment Major Product Offerings
  7.9.4 BioMerieux HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.9.5 BioMerieux Key News
7.10 MedMira
  7.10.1 MedMira Corporate Summary
  7.10.2 MedMira Business Overview
  7.10.3 MedMira HIV Diagnosis and Treatment Major Product Offerings
  7.10.4 MedMira HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.10.5 MedMira Key News
7.11 Hologic
  7.11.1 Hologic Corporate Summary
  7.11.2 Hologic Business Overview
  7.11.3 Hologic HIV Diagnosis and Treatment Major Product Offerings
  7.11.4 Hologic HIV Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.11.5 Hologic Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HIV Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. HIV Diagnosis and Treatment Market Drivers in Global Market
Table 3. HIV Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of HIV Diagnosis and Treatment in Global Market
Table 5. Top HIV Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 HIV Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HIV Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HIV Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HIV Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Siemens Healthcare Corporate Summary
Table 31. Siemens Healthcare HIV Diagnosis and Treatment Product Offerings
Table 32. Siemens Healthcare HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott HIV Diagnosis and Treatment Product Offerings
Table 35. Abbott HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche HIV Diagnosis and Treatment Product Offerings
Table 38. Roche HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Corporate Summary
Table 40. Bio-Rad HIV Diagnosis and Treatment Product Offerings
Table 41. Bio-Rad HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. QIAGEN Corporate Summary
Table 43. QIAGEN HIV Diagnosis and Treatment Product Offerings
Table 44. QIAGEN HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Danaher Corporate Summary
Table 46. Danaher HIV Diagnosis and Treatment Product Offerings
Table 47. Danaher HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. BD Corporate Summary
Table 49. BD HIV Diagnosis and Treatment Product Offerings
Table 50. BD HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Merck Corporate Summary
Table 52. Merck HIV Diagnosis and Treatment Product Offerings
Table 53. Merck HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. BioMerieux Corporate Summary
Table 55. BioMerieux HIV Diagnosis and Treatment Product Offerings
Table 56. BioMerieux HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. MedMira Corporate Summary
Table 58. MedMira HIV Diagnosis and Treatment Product Offerings
Table 59. MedMira HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Hologic Corporate Summary
Table 61. Hologic HIV Diagnosis and Treatment Product Offerings
Table 62. Hologic HIV Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HIV Diagnosis and Treatment Segment by Type in 2021
Figure 2. HIV Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global HIV Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Siemens Healthcare HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. QIAGEN HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Danaher HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BD HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Merck HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioMerieux HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. MedMira HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Hologic HIV Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)